StockIQ.techSanofi (SAN.PA) Stock Analysis
Free AI-powered analysis and research for Sanofi stock
Sector: Healthcare
SAN.PA snapshot
Data as of 4 Nov 2026 close. Updated daily.
Sanofi scores 50/100 on StockIQ's model, which reads as mixed signals overall. The price is above its 200-day average and at 68% of its 52-week range, down 2.6% over the past year. Latest reported figures show a profit margin of 8.1%, return on equity of 5.7% and revenue growth of +14.6%.
What is driving the score
- RSI Very High (81): -5
- Uptrend: +8
- MACD Bullish: +8
- Low Liquidity (0.99 Current Ratio): -10
- Above MA200: +4
- Underperforming (-2.6% over 1 year): -5
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full SAN.PA report
Sanofi (SAN.PA) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze SAN.PA Now →📰 Latest Update
CNS Summit Announces Sanofi as No. 1 in the 2026 Digital Innovation Index
Wed, November 4, 2026 at 5:00 PM UTC 3 min read
Sanofi has been ranked first in the 2026 CNS Summit Digital Innovation Index, which evaluates pharmaceutical companies on their digital initiatives and investments. The Index, now in its 11th year, recognized Sanofi for its comprehensive integration of digital and AI technologies across research, clinical development, and commercial operations. Other top companies included Eli Lilly and AstraZeneca, with Roche, Novo Nordisk, and Recursion leading in specific categories.